GlassScriptPhysician profile
Stephanie E Spicer
NPI 1578593398
$8,626.53
in general payments reported to CMS, 2019-2025
24 companies · $2,105 in 2025
The $2,105 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.30 · 2020: $924 · 2021: $1,906 · 2022: $1,473 · 2023: $1,145 · 2024: $1,022 · 2025: $2,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,749 · Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,748.71 |
| Food and Beverage | $1,524.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,991.05 | 2021-2024 | |
| Lifenet Health | $1,317.29 | 2025 | Theragenesis Wound Matrix |
| Medwest Associates | $1,200.00 | 2022 | |
| Biotissue Holdings INC. | $762.96 | 2020 | |
| Medical Device Business Services, INC. | $678.35 | 2023 | Na |
| Zimmer Biomet Holdings, INC. | $557.09 | 2020-2023 | Stratum Foot Plating System |
| Depuy Synthes Sales INC. | $315.89 | 2022-2025 | Motoband, N/A, Minibunion |
| Organogenesis INC. | $315.58 | 2021-2022 | |
| Amgen INC. | $311.49 | 2024 | Krystexxa |
| Arthrex, INC. | $288.20 | 2025 | |
| Lightbody Medical Technologies INC | $237.74 | 2025 | |
| Stryker Corporation | $138.16 | 2025 | Limflow System, Metal Hemi, Css Cannulated Screw System |
| Horizon Therapeutics Plc | $136.07 | 2020-2023 | Krystexxa |
| Ibsa Pharma INC. | $125.00 | 2023 | Licart |
| Integra Lifesciences Corporation | $48.60 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $47.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Osteomed LLC | $43.14 | 2019-2020 | |
| Melinta Therapeutics, LLC | $21.79 | 2022 | |
| Averitas Pharma INC. | $20.62 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $19.27 | 2025 | |
| Wright Medical Technology, INC. | $14.79 | 2019 | |
| Smith+Nephew, INC. | $13.21 | 2019 | |
| Orthofix Medical, INC. | $13.15 | 2020 | |
| Fusion Orthopedics USA, LLC | $9.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Spicer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.